MGTX Long Call Strategy

MGTX (MeiraGTx Holdings plc), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

MGTX (MeiraGTx Holdings plc) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $922.8M, a beta of 1.24 versus the broader market, a 52-week range of 4.58-11.85, average daily share volume of 694K, a public-listing history dating back to 2018, approximately 375 full-time employees. These structural characteristics shape how MGTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.24 places MGTX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long call on MGTX?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current MGTX snapshot

As of May 15, 2026, spot at $9.47, ATM IV 200.40%, IV rank 37.06%, expected move 57.45%. The long call on MGTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on MGTX specifically: MGTX IV at 200.40% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 57.45% (roughly $5.44 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MGTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on MGTX should anchor to the underlying notional of $9.47 per share and to the trader's directional view on MGTX stock.

MGTX long call setup

The MGTX long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MGTX near $9.47, the first option leg uses a $9.47 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MGTX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MGTX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$9.47N/A

MGTX long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

MGTX long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on MGTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on MGTX

Long calls on MGTX express a bullish thesis with defined risk; traders use them ahead of MGTX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

MGTX thesis for this long call

The market-implied 1-standard-deviation range for MGTX extends from approximately $4.03 on the downside to $14.91 on the upside. A MGTX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current MGTX IV rank near 37.06% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on MGTX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, MGTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MGTX-specific events.

MGTX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MGTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MGTX alongside the broader basket even when MGTX-specific fundamentals are unchanged. Long-premium structures like a long call on MGTX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current MGTX chain quotes before placing a trade.

Frequently asked questions

What is a long call on MGTX?
A long call on MGTX is the long call strategy applied to MGTX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With MGTX stock trading near $9.47, the strikes shown on this page are snapped to the nearest listed MGTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are MGTX long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the MGTX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 200.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a MGTX long call?
The breakeven for the MGTX long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MGTX market-implied 1-standard-deviation expected move is approximately 57.45%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on MGTX?
Long calls on MGTX express a bullish thesis with defined risk; traders use them ahead of MGTX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current MGTX implied volatility affect this long call?
MGTX ATM IV is at 200.40% with IV rank near 37.06%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related MGTX analysis